Open New Markets: How Biosimilar Clinical Trials Drive Access, Profitability, and Global Expansion …
As the patents for blockbuster biologics expire, a new era of opportunity emerges, ushering in the rise of biosimilars. These biologic alternatives offer the promise of affordable care, broader global […]